A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)

This study has been terminated.

( Study was terminated at the request of the company due to the recall of marketed product in Europe. )

Study NCT00665522 Information provided by Alza Corporation, DE, USA

First Received: April 22, 2008 Last Updated: June 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2008
Estimated Primary Completion Date:	No date given